Insulet , Nasdaq: PODD
Manufactures an insulin infusion system for insulin-dependent diabetics.
Industry: Health Care
First Day Return: +6.4%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 02/14/2007 |
| Offer Price | $15.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 7.7 |
| Deal Size ($mm) | $116 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/14/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $116 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Bedford, MA, United States |
| Founded | 2000 |
| Employees at IPO | n/a |
| Website www.MyOmniPod.com | |
Insulet (PODD) Performance
